- Home
- CELC vs GNW Comparison
CELC vs GNW Comparison
Compare CELC & GNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CELC | GNW |
|---|---|---|
| Founded | 2011 | 1871 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Life Insurance |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.4B |
| IPO Year | 2017 | 2004 |
Fundamental Metrics
Financial Performance| Metric | CELC | GNW |
|---|---|---|
| Price | $104.77 | $8.93 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 1 |
| Target Price | ★ $100.13 | $10.00 |
| AVG Volume (30 Days) | 863.3K | ★ 3.7M |
| Earning Date | 11-12-2025 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 160.86 |
| EPS | N/A | ★ 0.52 |
| Revenue | N/A | ★ $7,299,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $15.57 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.58 | $5.99 |
| 52 Week High | $112.64 | $9.28 |
Technical Indicators
Market Signals| Indicator | CELC | GNW |
|---|---|---|
| Relative Strength Index (RSI) | 63.88 | 48.74 |
| Support Level | $98.50 | $8.86 |
| Resistance Level | $103.09 | $9.19 |
| Average True Range (ATR) | 3.54 | 0.16 |
| MACD | -0.65 | -0.03 |
| Stochastic Oscillator | 78.85 | 19.57 |
Price Performance
Historical ComparisonAbout CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About GNW Genworth Financial Inc
Genworth Financial Inc is a diversified insurance holding company that provides various mortgage and life insurance products. The company has three main operating business segments: Enact, Life and Annuities segment and Long-Term Care Insurance. The company's product portfolio includes various financial products such as traditional life insurance, mortgage insurance, fixed annuities, and variable annuities. Majority of the revenue is generated by the Enact segment. The company earns maximum of its revenue in the United States.